Cel-Sci
CVM
#9766
Rank
C$71.97 M
Marketcap
C$9.00
Share price
2.54%
Change (1 day)
-61.78%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of June 2025 : C$2.5 Million

According to Cel-Sci 's latest financial reports the company has C$2.5 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30C$6.4 M13.76%
2023-09-30C$5.63 M-81.96%
2022-09-30C$31.23 M-41.65%
2021-09-30C$53.54 M159.47%
2020-09-30C$20.63 M84.53%
2019-09-30C$11.18 M-15.53%
2018-09-30C$13.23 M350.41%
2017-09-30C$2.93 M-23.48%
2016-09-30C$3.84 M-49.64%
2015-09-30C$7.62 M-20.06%
2014-09-30C$9.54 M22107.68%
2013-09-30C$0.04 M-98.89%
2012-09-30C$3.87 M-12.17%
2011-09-30C$4.41 M-83.88%
2010-09-30C$27.38 M-24.76%
2009-09-30C$36.4 M3657.1%
2008-09-30C$0.96 M-91.11%
2007-09-30C$10.9 M20.84%
2006-09-30C$9.02 M293.51%
2005-09-30C$2.29 M-57.34%
2004-09-30C$5.37 M127.94%
2003-09-30C$2.35 M-28.14%
2002-09-30C$3.28 M-12.59%
2001-09-30C$3.75 M-76.62%
2000-09-30C$16.05 M85.14%
1999-09-30C$8.67 M-54.54%
1998-09-30C$19.07 M294.29%
1997-09-30C$4.83 M1.5%
1996-09-30C$4.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
C$12.63 M 404.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.29 B 11,773.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$13.18 B 526,711.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.65 B 26,173.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.07 B 122,776.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
C$25.91 B 1,035,229.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.34 B 13,593.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$4.25 M 69.95%๐Ÿ‡บ๐Ÿ‡ธ USA